These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 23437942)

  • 1. A comparison model for measuring individual agreement.
    Lin L; Hedayat AS; Tang Y
    J Biopharm Stat; 2013 Mar; 23(2):322-45. PubMed ID: 23437942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unified approach for assessing agreement for continuous and categorical data.
    Lin L; Hedayat AS; Wu W
    J Biopharm Stat; 2007; 17(4):629-52. PubMed ID: 17613645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bootstrap in bioequivalence studies.
    Pigeot I; Hauschke D; Shao J
    J Biopharm Stat; 2011 Nov; 21(6):1126-39. PubMed ID: 22023681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian approach to average bioequivalence using Bayes' factor.
    Ghosh P; Khattree R
    J Biopharm Stat; 2003 Nov; 13(4):719-34. PubMed ID: 14584718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified large sample approach in the assessment of population bioequivalence.
    Quiroz J; Ting N; Wei GC; Burdick RK
    J Biopharm Stat; 2000 Nov; 10(4):527-44. PubMed ID: 11104391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing rater agreement using marginal association models.
    Perkins SM; Becker MP
    Stat Med; 2002 Jun; 21(12):1743-60. PubMed ID: 12111909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing intra, inter and total agreement with replicated readings.
    Barnhart HX; Song J; Haber MJ
    Stat Med; 2005 May; 24(9):1371-84. PubMed ID: 15570569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing individual bioequivalence using the structural equation model.
    Carrasco JL; Jover L
    Stat Med; 2003 Mar; 22(6):901-12. PubMed ID: 12627408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tests for individual and population bioequivalence based on generalized p-values.
    McNally RJ; Iyer H; Mathew T
    Stat Med; 2003 Jan; 22(1):31-53. PubMed ID: 12486750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall indices for assessing agreement among multiple raters.
    Jang JH; Manatunga AK; Taylor AT; Long Q
    Stat Med; 2018 Dec; 37(28):4200-4215. PubMed ID: 30062738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of moment-based and probability-based criteria for assessment of follow-on biologics.
    Chow SC; Hsieh TC; Chi E; Yang J
    J Biopharm Stat; 2010 Jan; 20(1):31-45. PubMed ID: 20077247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous estimation of intrarater and interrater agreement for multiple raters under order restrictions for a binary trait.
    Lester Kirchner H; Lemke JH
    Stat Med; 2002 Jun; 21(12):1761-72. PubMed ID: 12111910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative confidence intervals for the assessment of bioequivalence in four-period cross-over designs.
    Quiroz J; Ting N; Wei GC; Burdick RK
    Stat Med; 2002 Jul; 21(13):1825-47. PubMed ID: 12111892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kullback-Leibler divergence for evaluating bioequivalence.
    Dragalin V; Fedorov V; Patterson S; Jones B
    Stat Med; 2003 Mar; 22(6):913-30. PubMed ID: 12627409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective number of subjects and number of raters for inter-rater reliability studies.
    Saito Y; Sozu T; Hamada C; Yoshimura I
    Stat Med; 2006 May; 25(9):1547-60. PubMed ID: 16143966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Applying multilevel models in evaluation of bioequivalence (I)].
    Liu QL; Shen ZZ; Chen F; Li XS; Yang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Dec; 30(12):1302-6. PubMed ID: 20193320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of changing the bioequivalence range from (0.80, 1.20) to (0.80, 1.25) on the power and sample size.
    Steinijans VW; Hauck WW; Diletti E; Hauschke D; Anderson S
    Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):571-5. PubMed ID: 1473872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two one-sided tests procedure for assessment of individual bioequivalence.
    Liu J; Chow SC
    J Biopharm Stat; 1997 Mar; 7(1):49-61. PubMed ID: 9056588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing individual bioequivalence with high-order cross-over designs: a unified procedure.
    Hsuan FC; Reeve R
    Stat Med; 2003 Sep; 22(18):2847-60. PubMed ID: 12953284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing individual agreement.
    Barnhart HX; Kosinski AS; Haber MJ
    J Biopharm Stat; 2007; 17(4):697-719. PubMed ID: 17613649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.